Nonribosomal peptide synthetases (NRPSs) assemble a remarkably diverse array of peptide-based natural products. Several different strategies are employed by Nature for nonribosomal peptide diversification, including the biosynthesis and incorporation of non-proteinogenic amino acids, conjugation with fatty acid and polyketide chains, promiscuous NRPS subunit recognition, and a various on- and post-NRPS modifying enzymes. In this lecture, I will describe efforts to understand diversification mechanisms in the biosynthesis of several unusual nonribosomal peptides, including the EPA-approved herbicide thaxtomin A,1,2 the epoxyketone proteasome inhibitors TMC-86A and eponemycin,3 FR-901375 and related histone deactylase inhibitors, and icosalide A1.4